| __timestamp | Johnson & Johnson | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 21954000000 | 4042025 |
| Thursday, January 1, 2015 | 21203000000 | 5279557 |
| Friday, January 1, 2016 | 19945000000 | 8073913 |
| Sunday, January 1, 2017 | 21420000000 | 44864073 |
| Monday, January 1, 2018 | 22540000000 | 53488904 |
| Tuesday, January 1, 2019 | 22178000000 | 65896361 |
| Wednesday, January 1, 2020 | 22084000000 | 69968267 |
| Friday, January 1, 2021 | 20118000000 | 92047281 |
| Saturday, January 1, 2022 | 19046000000 | 131819000 |
| Sunday, January 1, 2023 | 20112000000 | 87501000 |
Infusing magic into the data realm
In the world of pharmaceuticals, Johnson & Johnson and Pharming Group N.V. present a fascinating study in contrasts. Over the past decade, Johnson & Johnson, a titan in the industry, has consistently reported Selling, General, and Administrative (SG&A) expenses averaging around $21 billion annually. In contrast, Pharming Group N.V., a smaller player, has seen its SG&A expenses grow from a modest $4 million in 2014 to over $130 million in 2022, marking a staggering increase of over 3,000%.
From 2014 to 2023, Johnson & Johnson's SG&A expenses have shown a slight decline, with a notable dip in 2022. Meanwhile, Pharming Group N.V. has experienced a dramatic rise, reflecting its aggressive expansion and increased market presence. This divergence highlights the different strategies and market dynamics faced by large and small pharmaceutical companies.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Pharming Group N.V.
Johnson & Johnson and Merck & Co., Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Amgen Inc.
Breaking Down SG&A Expenses: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Johnson & Johnson and BioMarin Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: Johnson & Johnson vs Alkermes plc
Comparing SG&A Expenses: Viatris Inc. vs Pharming Group N.V. Trends and Insights
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Pharming Group N.V.
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
Pharming Group N.V. vs HUTCHMED (China) Limited: SG&A Expense Trends